Structures by: Tsue H.
Total: 22
C48H68N4O4
C48H68N4O4
Organic letters (2005) 7, 11 2165-2168
a=23.64(1)Å b=16.890(6)Å c=12.682(5)Å
α=90° β=116.40(3)° γ=90°
C55H75N5O5
C55H75N5O5
Organic letters (2011) 13, 3 490-493
a=17.1150Å b=13.1050Å c=26.8951Å
α=90.0000° β=109.3741° γ=90.0000°
C105.50H143N8O8.50
C105.50H143N8O8.50
Organic letters (2006) 8, 26 5991-5994
a=24.468(2)Å b=24.214(3)Å c=19.3043(19)Å
α=90.0000° β=102.267(7)° γ=90.0000°
C36H53N2O5
C36H53N2O5
Soft matter (2015) 11, 27 5563-5570
a=9.576(3)Å b=13.430(4)Å c=26.522(8)Å
α=90.00° β=90.00° γ=90.00°
C44H60N4O4
C44H60N4O4
CrystEngComm (2012) 14, 3 1021
a=12.774(4)Å b=16.152(5)Å c=21.355(7)Å
α=90.00° β=101.427(4)° γ=90.00°
C44.4H60N4O4.8
C44.4H60N4O4.8
CrystEngComm (2012) 14, 3 1021
a=12.836(8)Å b=16.215(9)Å c=21.460(13)Å
α=90.00° β=101.817(10)° γ=90.00°
C67H87N5O5
C67H87N5O5
CrystEngComm (2013) 15, 8 1536
a=13.2467(3)Å b=28.8514(8)Å c=32.3635(8)Å
α=90.0000° β=90.0000° γ=90.0000°
C20H16N2
C20H16N2
Journal of the Chemical Society, Perkin Transactions 1 (1999) 24 3677
a=31.695(2)Å b=31.695(2)Å c=7.7985(7)Å
α=90° β=90° γ=120°
C22H20N2
C22H20N2
Journal of the Chemical Society, Perkin Transactions 1 (1999) 24 3677
a=21.343(3)Å b=20.316(2)Å c=7.5398(7)Å
α=90° β=90° γ=90°
C14H14O3,0.5(C10H8N2)
C14H14O3,0.5(C10H8N2)
CrystEngComm (2014) 16, 26 5811
a=7.624(6)Å b=5.800(4)Å c=36.02(3)Å
α=90.00° β=90.017(8)° γ=90.00°
RS-Naproxen-Piperidine
C14H13O3,0.5(C4H10N2)
CrystEngComm (2014) 16, 26 5811
a=7.966(4)Å b=6.012(3)Å c=28.985(15)Å
α=90.00° β=91.739(7)° γ=90.00°
2(C14H14O3),C10H8N2
2(C14H14O3),C10H8N2
CrystEngComm (2014) 16, 26 5811
a=15.206(6)Å b=5.766(2)Å c=19.370(8)Å
α=90.00° β=111.189(5)° γ=90.00°
C44H60N4O4
C44H60N4O4
Organic letters (2011) 13, 3 490-493
a=12.7494(7)Å b=16.1119(8)Å c=21.2918(11)Å
α=90.00° β=101.3320(18)° γ=90.00°
C27H33BrN2O7S
C27H33BrN2O7S
Crystal Growth & Design (2007) 7, 9 1643
a=6.2494(4)Å b=15.578(2)Å c=15.620(2)Å
α=110.665(5)° β=100.549(6)° γ=82.736(7)°
C27H33ClN2O7S
C27H33ClN2O7S
Crystal Growth & Design (2007) 7, 9 1643
a=6.246(4)Å b=15.485(10)Å c=15.505(12)Å
α=110.59(5)° β=96.95(6)° γ=79.95(5)°
C30H38IN2O7.5S
C30H38IN2O7.5S
Crystal Growth & Design (2015) 15, 6 3052
a=13.672(3)Å b=14.846(4)Å c=16.641(4)Å
α=102.543(3)° β=102.772(3)° γ=103.8523(18)°
C30H38N2O7S
C30H38N2O7S
Crystal Growth & Design (2015) 15, 6 3052
a=12.070(4)Å b=16.257(5)Å c=14.625(5)Å
α=90.00° β=91.229(4)° γ=90.00°
C89H133N7O7
C89H133N7O7
Journal of Organic Chemistry (2008) 73, 7748-7755
a=18.4577(13)Å b=24.5362(19)Å c=19.5227(14)Å
α=90.0000° β=101.494(2)° γ=90.0000°
C6H13NO2
C6H13NO2
Crystal Growth & Design (2010) 10, 6 2668
a=13.9853(15)Å b=5.3995(14)Å c=5.154(4)Å
α=111.471(6)° β=96.760(8)° γ=86.579(7)°
C3H7NO2
C3H7NO2
Crystal Growth & Design (2010) 10, 6 2668
a=12.0067(16)Å b=6.0290(6)Å c=5.8318(6)Å
α=90.0000° β=90.0000° γ=90.0000°
S-Naproxen-Piperidine
2(C14H13O3),C4H10N2
CrystEngComm (2014) 16, 26 5811
a=8.029(4)Å b=6.118(3)Å c=28.045(14)Å
α=90.00° β=93.990(7)° γ=90.00°
C68H81Cl9O8
C68H81Cl9O8
Chemistry Letters (2005) 34, 7 1030
a=17.4063(8)Å b=13.0233(6)Å c=30.268(1)Å
α=90° β=93.173(3)° γ=90°